🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VYN
$VYNE
🔒 US EquitiesVYNE Therapeutics INC
AVG HISTORICAL GAP
-0.44%
MAX GAP RECORD
-10.26%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VYNE
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VYNE
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Feb 27, 2026 Earnings Release 2026-02-27 (BEFORE OPEN) |
-1.67%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
+2.10%
|
| Mar 06, 2025 Earnings Release 2025-03-06 (BEFORE OPEN) |
-1.26%
|
| Aug 14, 2024 Earnings Release 2024-08-14 (BEFORE OPEN) |
-1.17%
|
| Nov 13, 2023 Earnings Release 2023-11-13 (BEFORE OPEN) |
-10.26%
|
| May 11, 2023 Earnings Release 2023-05-11 (AFTER CLOSE) |
+10.16%
|
| Mar 09, 2023 Earnings Release 2023-03-09 (AFTER CLOSE) |
-1.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.9%
Bullish Gaps (2)
Bearish Gaps (5)
Neutral / Flat (0)
📖 Intelligence Summary
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Stewartsville, NJ.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗